We’re using genomics and precision medicine to help you characterize diseases and advanced therapeutics.
Tapestri enables precision disease profiling and therapeutic characterization at the single-cell level to empower next-generation therapies.
Resolving complex biology at the single cell level is crucial to the understanding of disease, and ultimately unlocking novel therapies. While advances have been made in precision medicine, challenges in fully understanding disease profiles at the clonal level and comprehensive characterization of ex vivo cell therapeutics still remain. Clinicians and drug developers require better tools to unravel the complex heterogeneity underlying disease progression, treatment response, and therapeutic resistance. Furthermore, they need precise and comprehensive solutions for product characterization, as they move from the bench to the clinic.
The Tapestri Platform is the only single-cell platform that enables targeted and high-throughput single-cell DNA sequencing and proteogenomic characterization. Clinicians and researchers can leverage Tapestri to measure both genotype and phenotype data from the same cell, across thousands of single cells, to provide the high-resolution lens necessary to characterize the clonal heterogeneity across an entire patient journey. Additionally, the single-cell multi-omics capability enables drug developers to profile disease accurately over time and measure the variation that exists in therapeutic agents and their effects early in discovery — ultimately empowering them to accelerate the discovery, development, and delivery of precision medicine.
LEARN MORE
Mission Bio partners with pharma and biopharma companies across drug and advanced therapy development programs to implement proven single-cell multi-omics capabilities into discovery, translational, and clinical research efforts.
Todd Druley, MD, PhD, Chief Medical Officer, Mission Bio
Use Tapestri Designer to design a custom panel tailored to your needs.
Contact US
